European Archives - Page 699 of 1368 - European Medical Journal

EMJ Cardiology 10 [Supplement 7] 2022

Despite the increasing prevalence of raised blood pressure and hypertension, many patients remain undiagnosed due to a lack of symptoms. Hypertension presents considerable risks for patients with cardiovascular diseases, and currently has limited effective interventions.

Underdiagnosis and Poor Adherence Are Contributing to Rising Cases of Hypertension

Essential hypertension, a significant risk factor for cardiovascular diseases (CVD), kidney failure, and all-cause mortality, is largely reversible with lifestyle changes and highly efficacious medications. However, the prevalence of raised blood pressure (BP) is increasing globally. Considering its lack of symptoms, many people remain undiagnosed and unaware of the risks. In addition, a lack of perceived benefit makes adhering to pharmacological and non-pharmacological interventions challenging for patients.

Current challenges and future perspectives in Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis

As part of Novartis’ continued commitment to medical education in rheumatology. We Invite you to our faculty as they discuss: -The disease state of JPsA and ERA and the impact of diagnosis, clinical features, and disease activity on patients and caregivers. -The importance of both the patient perspective and the unmet needs for optimizing the management of JPsA and ERA -Clinical evidence for IL17 inhibition in the management of ERA and JPsA.

EMJ

Infographic: Rayaldee®: For Early and Sustained SHPT Control

Secondary hyperparathyroidism (SHPT) is a common and early complication of chronic kidney disease (CKD). Patients with uncontrolled SHPT have high parathyroid hormone (PTH) levels due to mineral metabolism disturbances of several biochemical parameters. These elevated PTH levels put patients at an increased risk of cardiovascular disease and bone fractures. This infographic explores the current treatments available to treat mineral bone disease in CKD (CKD-MBD) and their failure to achieve balance across key disease parameters.

Channelling the myotonia diagnosis: ICNMD symposium presentations

Watch full presentations given by Prof. Dr Kristl Claeys, Dr Guillaume Bassez and Prof. John Vissing at the Lupin-sponsored symposium at the 17th International Congress on Neuromuscular Diseases, in July 2022, in Brussels, Belgium.

Unpicking pharma’s reputation in pop culture

Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.

Spencer Gore named among UK’s Top 50 Most Ambitious Business Leaders for 2022

Spencer Gore, Founder of EMJ has been named as one of The LDC Top 50 Most Ambitious Business Leaders for 2022.

Overview of Obstructive Hypertrophic Cardiomyopathy

This episode explores various aspects of obstructive hypertrophic cardiomyopathy (HCM), and features expert insights from Antonis Pantazis.

Spotlight on MTX therapy in patients with RA – increasing vaccination response and combination therapy

In this podcast, listeners can expect two highly interesting interviews with two well-known experts in the field of rheumatoid arthritis.

An Observational Study on Unique High Resolution Computed Tomography Pattern of Post-COVID Pulmonary Fibrosis

The parenchyma of the lungs can undergo fibrosis due to known aetiology such as radiation or drug induced fibrosis; occupational or connective tissue related interstitial lung disease; or it may have genetic basis or remain idiopathic, as in idiopathic pulmonary fibrosis.